H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling

Oncogene

Volumn 33, Issue 18, 2014, Pages 2329-2340

  Rimessi, A ^a   Marchi, S ^a   Patergnani, S ^a   Pinton, P ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Apoptosis; Calcium signaling; Caveolin 1; Mitochondria; Oncogenic H Ras

Indexed keywords

CALCIUM; CAVEOLIN 1;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CARCINOGENESIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; ONCOGENE H RAS; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CALCIUM; CALCIUM SIGNALING; CAVEOLIN 1; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; MICE; MITOCHONDRIA; NIH 3T3 CELLS;

EID: 84899965504     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.192     Document Type: Article

References (60)

1. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev 2003; 3: 459-465.
2. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat Rev 2003; 3: 11-22.
3. Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N et al. Essential role for oncogenic Ras in tumour maintenance. Nature 1999; 400: 468-472.
4. Weinstein IB, Joe A. Oncogene addiction. Cancer Res 2008; 68: 3077-3080 discussion 80.
5. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J General Physiol 1927; 8: 519-530.
6. Gough DJ, Corlett A, Schlessinger K, Wegrzyn J, Larner AC, Levy DE. Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science (New York, NY 2009; 324: 1713-1716.
7. Hu Y, Lu W, Chen G, Wang P, Chen Z, Zhou Y et al. K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res 2012; 22: 399-412.
8. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 2008; 18: 165-173.
9. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472-482.
10. Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S et al. Mitochondrial Ca(2þ) and apoptosis. Cell Calcium 2012; 52: 36-43.
11. Ralph SJ, Rodriguez-Enriquez S, Neuzil J, Saavedra E, Moreno-Sanchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation -why mitochondria are targets for cancer therapy. Mol Aspects Med 2010; 31: 145-170.
12. Clapham DE. Calcium signaling. Cell 2007; 131: 1047-1058.
13. Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R. The Ca2þ concentration of the endoplasmic reticulum is a key determinant of ceramideinduced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J 2001; 20: 2690-2701.
14. Liu X, Hajnoczky G. Ca2þ-dependent regulation of mitochondrial dynamics by the Miro-Milton complex. Int J Biochem Cell Biol 2009; 41: 1972-1976.
15. Giorgi C, Agnoletto C, Bononi A, Bonora M, De Marchi E, Marchi S et al. Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion 2012; 12: 77-85.
16. Peng TI, Jou MJ. Oxidative stress caused by mitochondrial calcium overload. Ann NY Acad Sci 2010; 1201: 183-188.
17. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000; 1: 11-21.
18. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 31-39.
19. Thomas CM, Smart EJ. Caveolae structure and function. J Cell Mol Med 2008; 12: 796-809.
20. Razani B, Schlegel A, Lisanti MP. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci 2000; 113(Pt 12): 2103-2109.
21. Williams TM, Lisanti MP. The Caveolin genes: from cell biology to medicine. Ann Med 2004; 36: 584-595.
22. Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 2008; 48: 359-391.
23. Fujimoto T. Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 1993; 120: 1147-1157.
24. Fujimoto T, Nakade S, Miyawaki A, Mikoshiba K, Ogawa K. Localization of inositol 1,4,5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol 1992; 119: 1507-1513.
25. Jorgensen AO, Shen AC, Arnold W, Leung AT, Campbell KP. Subcellular distribution of the 1,4-dihydropyridine receptor in rabbit skeletal muscle in situ: an immunofluorescence and immunocolloidal gold-labeling study. J Cell Biol 1989; 109: 135-147.
26. Kifor O, Diaz R, Butters R, Kifor I, Brown EM. The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 1998; 273: 21708-21713.
27. Isshiki M, Ando J, Yamamoto K, Fujita T, Ying Y, Anderson RG. Sites of Ca(2þ) wave initiation move with caveolae to the trailing edge of migrating cells. J Cell Sci 2002; 115(Pt 3): 475-484.
28. Isshiki M, Anderson RG. Function of caveolae in Ca2þ entry and Ca2þ-dependent signal transduction. Traffic (Copenhagen, Denmark) 2003; 4: 717-723.
29. Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc 2009; 4: 1582-1590.
30. Giorgi C, De Stefani D, Bononi A, Rizzuto R, Pinton P. Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol 2009; 41: 1817-1827.
31. Patergnani S, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E et al. Calcium signaling around mitochondria associated membranes (MAMs) Cell Commun Signal 2011; 9: 19.
32. Pinton P, Rimessi A, Romagnoli A, Prandini A, Rizzuto R. Biosensors for the detection of calcium and pH. Methods Cell Biol 2007; 80: 297-325.
33. Pantoja C, Serrano M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999; 18: 4974-4982.
34. Gallimore PH, Grand RJ, Byrd PJ. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes. Anticancer Res 1986; 6(3 Pt B): 499-508.
35. Ferdek PE, Gerasimenko JV, Peng S, Tepikin AV, Petersen OH, Gerasimenko OV. A novel role for Bcl-2 in regulation of cellular calcium extrusion. Curr Biol 2012; 22: 1241-1246.
36. Krejci P, Prochazkova J, Smutny J, Chlebova K, Lin P, Aklian A et al. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence. Bone 2010; 47: 102-110.
37. Koleske AJ, Baltimore D, Lisanti MP. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 1995; 92: 1381-1385.
38. Hayer A, Stoeber M, Ritz D, Engel S, Meyer HH, Helenius A. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J Cell Biol 2010; 191: 615-629.
39. Pozzan T, Rizzuto R, Volpe P, Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 1994; 74: 595-636.
40. Lee SW, Reimer CL, Oh P, Campbell DB, Schnitzer JE. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene 1998; 16: 1391-1397.
41. Racine C, Belanger M, Hirabayashi H, Boucher M, Chakir J, Couet J. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem Biophys Res Commun 1999; 255: 580-586.
42. Bender F, Montoya M, Monardes V, Leyton L, Quest AF. Caveolae and caveolaelike membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol Res 2002; 35: 151-167.
43. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 2001; 159: 1635-1643.
44. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 2001; 158: 833-839.
45. Park DS, Razani B, Lasorella A, Schreiber-Agus N, Pestell RG, Iavarone A et al. Evidence that Myc isoforms transcriptionally repress caveolin-1 gene expression via an INR-dependent mechanism. Biochemistry 2001; 40: 3354-3362.
46. Liu P, Rudick M, Anderson RG. Multiple functions of caveolin-1. J Biol Chem 2002; 277: 41295-41298.
47. Rajjayabun PH, Garg S, Durkan GC, Charlton R, Robinson MC, Mellon JK. Caveolin-1 expression is associated with high-grade bladder cancer. Urology 2001; 58: 811-814.
48. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 1998; 17: 6633-6648.
49. Volonte D, Zhang K, Lisanti MP, Galbiati F. Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell 2002; 13: 2502-2517.
50. Hulit J, Bash T, Fu M, Galbiati F, Albanese C, Sage DR et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J Biol Chem 2000; 275: 21203-21209.
51. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L et al. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/ p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001; 12: 2229-2244.
52. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 1996; 271: 9690-9697.
53. Murata T, Lin MI, Stan RV, Bauer PM, Yu J, Sessa WC. Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells. J Biol Chem 2007; 282: 16631-16643.
54. Adebiyi A, Narayanan D, Jaggar JH. Caveolin-1 assembles type 1 inositol 1,4,5-trisphosphate receptors and canonical transient receptor potential 3 channels into a functional signaling complex in arterial smooth muscle cells. J Biol Chem 2011; 286: 4341-4348.
55. Rimessi A, Giorgi C, Pinton P, Rizzuto R. The versatility of mitochondrial calcium signals: from stimulation of cell metabolism to induction of cell death. Biochimica et biophysica acta 2008; 777: 808-816.
56. Berridge MV, Tan AS. Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessing the Warburg effect. Rejuvenation Res 2010; 13: 139-141.
57. Pavlides S, Tsirigos A, Vera I, Flomenberg N, Frank PG, Casimiro MC et al. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling". Aging 2010; 2: 185-199.
58. Martinez-Outschoorn UE, Balliet RM, Rivadeneira DB, Chiavarina B, Pavlides S, Wang C et al. Oxidative stress in cancer associated fibroblasts drives tumorstroma co-evolution: A new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell cycle (Georgetown, Tex) 2010; 9: 3256-3276.
59. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25: 460-470.
60. Sano R, Annunziata I, Patterson A, Moshiach S, Gomero E, Opferman J et al. GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to Ca(2þ)-dependent mitochondrial apoptosis. Mol Cell 2009; 36: 500-511.